Collegium Pharmaceutical Inc — balance (NASDAQ:COLL) | MetaTrader

Ver el calendario completo

Financials

Visión general Informes Estadísticas

Activos totales 643.84 M692.08 M1.17 B1.14 B1.66 B1.66 B Total de pasivos 457.81 M489.15 M979.29 M947.88 M1.43 B1.36 B Capital total 186.03 M202.93 M194.84 M195.43 M228.84 M301.68 M Total de pasivos y patrimonio neto 643.84 M692.08 M1.17 B1.14 B1.66 B1.66 B Deuda total 257.09 M249.99 M700.95 M667.17 M852.49 M809.33 M Deuda neta 92.47 M72.32 M535.49 M287.4 M602.34 M272.76 M

Noticias

Collegium Pharmaceutical, Inc. (COLL) Discusses Acquisition of AZSTARYS to Expand ADHD Portfolio and Accelerate Growth - Slideshow (NASDAQ:COLL) 2026-03-24

Collegium Pharmaceuticals: Another M&A Episode Adds To An Intriguing Case (NASDAQ:COLL)

Collegium Pharmaceutical, Inc. (COLL) Discusses Acquisition of AZSTARYS to Expand ADHD Portfolio and Accelerate Growth Transcript

Jefferies reitera recomendación de Compra en Collegium Pharmaceutical tras acuerdo de TDAH

Barclays reitera calificación de acciones de Collegium Pharmaceutical en Sobreponderar

Collegium Pharmaceutical adquirirá AZSTARYS por 650 millones de dólares

Collegium Pharmaceutical, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:COLL) 2026-03-01

Collegium Pharmaceutical (COLL) Reports Q4 Earnings: What Key Metrics Have to Say

Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Miss Estimates

Fármaco TDAH de Collegium crece pese a resultados bajo expectativas

Collegium Q4 2025 slides: ADHD drug surges despite earnings miss

Collegium Pharmaceutical se quedan por debajo de 0.10$ las previsiones de BPA en el cuarto trimestre del año